Northwestern Medicine Hematology and Oncology
Oncology
Dr. Neal P. Christiansen, MD
|
|
Give Review
Dr. Neal P. Christiansen practices Oncology. He attended Washington University School of Medicine in St. Louis. He received awards:"CMS Meaningful Use Stage 1 Certification". Neal Christiansen is also a published doctor. He has 26 publication published. The most recent publication is: A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia. He is registered with Medicare.
Publications
- Association Between African American Race and Outcomes in Patients With Nonmetastatic Triple-Negative Breast Cancer: A Retrospective Analysis by Using Results From the...
- Absenteeism and short-term disability associated with breast cancer.
- Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
- Early herpes zoster infection in adult patients with Hodgkin''s disease undergoing autologous bone marrow transplant.
- Combination chemotherapy with etoposide and 5-fluorouracil in advanced pancreatic adenocarcinoma.
- Lack of antiemetic effect of high-dose metoclopramide.
- Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
- Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outc...
- CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
- Allogeneic bone marrow transplantation for the treatment of adult acute leukemias.
- A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
- Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
- Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.
- Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
- High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myel...
- Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
- Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group.
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
- Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
- Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical...
- A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for ...
- Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
- Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first rem...
- Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma.
- Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trial.
Schools
Washington Univ Sch Of Med
Michael Reese Med Center
University Of Minnesota
Procedures Preformed
- Thoracentesis
Doctors Specialties
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Washington University School of Medicine in St. Louis
Hospital
-
Northwestern Lake Forest Hospital
Drug Facts
| NPI NUMBER | 1831170489 | |
| NPPES Provider LastName | CHRISTIANSEN | |
| NPPES Provider FirstName | NEAL | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 877.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 1.82 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831170489 |
| Last Name Of The Provider | CHRISTIANSEN |
| First Name Of The Provider | NEAL |
| View All |
Similar Doctors
|
Dr. Sonya M. Sharpless, MD
 This Doctor is OpenDoctor Recommended.
|